2025-7-15 17:50 |
Sonnet BioTherapeutics is no longer just a cancer drug developer. Its $888 million merger will place it among the largest HYPE holders, blurring the lines between traditional finance and decentralized protocols in a high-stakes treasury experiment. According to a July… origin »
Hype Token (HYPE) на Currencies.ru
|
|